The effect of human antibacterial peptide LL-37 in the pathogenesis of chronic obstructive pulmonary disease

Respiratory Medicine

Volumn 106, Issue 12, 2012, Pages 1680-1689

  Jiang, Yuan Yuan ^a   Xiao, Wei ^a   Zhu, Mao Xiang ^b   Yang, Zhi Hua ^b   Pan, Xiu Jie ^b   Zhang, Yi ^a   Sun, Cong Cong ^a   Xing, Ying ^c  

^a SHANDONG UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic obstructive pulmonary disease; Inflammation; Innate immune; LL 37

Indexed keywords

ANTIBACTERIAL PEPTIDE LL 37; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; POLYPEPTIDE ANTIBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AIRWAY OBSTRUCTION; APOPTOSIS; ARTICLE; BRONCHUS MUCOSA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH STATUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; INNATE IMMUNITY; LUNG ALVEOLUS EPITHELIUM; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SPUTUM ANALYSIS;

ANTIMICROBIAL CATIONIC PEPTIDES; APOPTOSIS; BRONCHI; CASE-CONTROL STUDIES; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNITY, INNATE; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; PULMONARY ALVEOLI; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MUCOSA; SMOKE; SPUTUM; TOBACCO PRODUCTS; TUMOR NECROSIS FACTOR-ALPHA; VITAL CAPACITY;

EID: 84867748126     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2012.08.018     Document Type: Article

References (36)

1. K.F. Rabe, S. Hurd, A. Anzueto, P.J. Barnes, S.A. Buist, and P. Calverley Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 176 6 2007 532 555
2. R.P. Schleimer Innate immune responses and chronic obstructive pulmonary disease: "Terminator" or "Terminator 2"? Proc Am Thorac Soc 2 4 2005 342 346 [discussion 371-342]
3. A.I. D'Hulst, T. Maes, K.R. Bracke, I.K. Demedts, K.G. Tournoy, and G.F. Joos Cigarette smoke-induced pulmonary emphysema in scid-mice. Is the acquired immune system required? Respir Res 6 2005 147
4. M. Zanetti, R. Gennaro, and D. Romeo Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain FEBS Lett 374 1 1995 1 5
5. I. Nagaoka, S. Hirota, F. Niyonsaba, M. Hirata, Y. Adachi, and H. Tamura Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells J Immunol 167 6 2001 3329 3338
6. K. De Smet, and R. Contreras Human antimicrobial peptides: defensins, cathelicidins and histatins Biotechnol Lett 27 18 2005 1337 1347
7. M.G. Scott, D.J. Davidson, M.R. Gold, D. Bowdish, and R.E. Hancock The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses J Immunol 169 7 2002 3883 3891
8. G.S. Tjabringa, J. Aarbiou, D.K. Ninaber, J.W. Drijfhout, O.E. Sorensen, and N. Borregaard The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor J Immunol 171 12 2003 6690 6696
9. A. Elssner, M. Duncan, M. Gavrilin, and M.D. Wewers A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release J Immunol 172 8 2004 4987 4994
10. R. Shaykhiev, C. Beisswenger, K. Kandler, J. Senske, A. Puchner, and T. Damm Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure Am J Physiol Lung Cell Mol Physiol 289 5 2005 L842 L848
11. R. Koczulla, G. von Degenfeld, C. Kupatt, F. Krotz, S. Zahler, and T. Gloe An angiogenic role for the human peptide antibiotic LL-37/hCAP-18 J Clin Invest 111 11 2003 1665 1672
12. Y.E. Lau, D.M. Bowdish, C. Cosseau, R.E. Hancock, and D.J. Davidson Apoptosis of airway epithelial cells: human serum sensitive induction by the cathelicidin LL-37 Am J Respir Cell Mol Biol 34 4 2006 399 409
13. C.D. Ciornei, A. Egesten, and M. Bodelsson Effects of human cathelicidin antimicrobial peptide LL-37 on lipopolysaccharide-induced nitric oxide release from rat aorta in vitro Acta Anaesthesiol Scand 47 2 2003 213 220
14. W. Xiao, Y.P. Hsu, A. Ishizaka, T. Kirikae, and R.B. Moss Sputum cathelicidin, urokinase plasminogen activation system components, and cytokines discriminate cystic fibrosis, COPD, and asthma inflammation Chest 128 4 2005 2316 2326
15. Y. Jiang, W. Xiao, Y. Zhang, and Y. Xing Urokinase-type plasminogen activator system and human cationic antimicrobial protein 18 in serum and induced sputum of patients with chronic obstructive pulmonary disease Respirology 15 6 2010 939 946
16. T.A. Seemungal, G.C. Donaldson, A. Bhowmik, D.J. Jeffries, and J.A. Wedzicha Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 161 5 2000 1608 1613
17. G.C. Donaldson, T.A. Seemungal, A. Bhowmik, and J.A. Wedzicha Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease Thorax 57 10 2002 847 852
18. Standardization of spirometry, 1994 update. American Thoracic Society Am J Respir Crit Care Med 152 3 1995 1107 1136
19. P.W. Jones Health status measurement in chronic obstructive pulmonary disease Thorax 56 11 2001 880 887
20. D. Brooks, S. Solway, and W.J. Gibbons ATS statement on six-minute walk test Am J Respir Crit Care Med 167 9 2003 1287
21. I. Pin, P.G. Gibson, R. Kolendowicz, A. Girgis-Gabardo, J.A. Denburg, and F.E. Hargreave Use of induced sputum cell counts to investigate airway inflammation in asthma Thorax 47 1 1992 25 29
22. M. Tsoumakidou, N. Tzanakis, and N.M. Siafakas Induced sputum in the investigation of airway inflammation of COPD Respir Med 97 8 2003 863 871
23. C. Carlsten, M.L. Aitken, and T.S. Hallstrand Safety of sputum induction with hypertonic saline solution in exercise-induced bronchoconstriction Chest 131 5 2007 1339 1344
24. C.L. Ordonez, N.R. Henig, N. Mayer-Hamblett, F.J. Accurso, J.L. Burns, and J.F. Chmiel Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis Am J Respir Crit Care Med 168 12 2003 1471 1475
25. G.H. Gudmundsson, B. Agerberth, J. Odeberg, T. Bergman, B. Olsson, and R. Salcedo The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes Eur J Biochem 238 2 1996 325 332
26. J.B. Cowland, A.H. Johnsen, and N. Borregaard hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules FEBS Lett 368 1 1995 173 176
27. J.W. Larrick, M. Hirata, R.F. Balint, J. Lee, J. Zhong, and S.C. Wright Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein Infect Immun 63 4 1995 1291 1297
28. M. Golec, C. Reichel, B. Mackiewicz, C. Skorska, K. Curzytek, and M. Lemieszek Cathelicidin LL-37, granzymes, TGF-beta1 and cytokines levels in induced sputum from farmers with and without COPD Ann Agric Environ Med 16 2 2009 289 297
29. O. Sorensen, K. Arnljots, J.B. Cowland, D.F. Bainton, and N. Borregaard The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils Blood 90 7 1997 2796 2803
30. J. von Haussen, R. Koczulla, R. Shaykhiev, C. Herr, O. Pinkenburg, and D. Reimer The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells Lung Cancer (Amsterdam, Netherlands) 59 1 2008 12 23
31. S.D. Aaron, K.L. Vandemheen, T. Ramsay, C. Zhang, Z. Avnur, and T. Nikolcheva Multianalyte profiling and variability of inflammatory markers in blood and induced sputum in patients with stable COPD Respir Res 11 2010 41
32. P.M. Henson, G.P. Cosgrove, and R.W. Vandivier State of the art. Apoptosis and cell homeostasis in chronic obstructive pulmonary disease Proc Am Thorac Soc 3 6 2006 512 516
33. K. Kuwano Epithelial cell apoptosis and lung remodeling Cell Mol Immunol 4 6 2007 419 429
34. Y. Kasahara, R.M. Tuder, C.D. Cool, D.A. Lynch, S.C. Flores, and N.F. Voelkel Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema Am J Respir Crit Care Med 163 3 Pt 1 2001 737 744
35. C.A. Owen Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease Int J Chron Obstruct Pulmon Dis 3 2 2008 253 268
36. R.M. Mroz, J. Noparlik, E. Chyczewska, J.J. Braszko, and A. Holownia Molecular basis of chronic inflammation in lung diseases: new therapeutic approach J Physiol Pharmacol 58 Suppl. 5(Pt 2) 2007 453 460